- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02792075
Prognosis of Coronary Stenosis Based on Intracoronary Imaging; A Multicenter, Prospective Observational Study (IRIS imaging)
April 3, 2023 updated by: Seung-Jung Park
The purpose of this study is to evaluate the prognosis of coronary stenosis based on intracoronary Imaging.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
4000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Busan, Korea, Republic of
- Recruiting
- Inje University Busan Paik Hospital
-
Contact:
- Tae-hyun Yang, MD
-
Principal Investigator:
- Tae-hyun Yang, MD
-
Cheonan, Korea, Republic of
- Recruiting
- Soon Chun Hyang University Hospital Cheonan
-
Contact:
- Seung-jin Lee, MD
-
Principal Investigator:
- Seung-jin Lee, MD
-
Daegu, Korea, Republic of
- Recruiting
- Keimyung University Dongsan Medical Center
-
Principal Investigator:
- Seung-Ho Huh, MD
-
Contact:
- Seung-Ho Huh, MD
-
Daejeon, Korea, Republic of
- Recruiting
- Chungnam National University Hospital
-
Contact:
- Jin-ok Jeong, MD
-
Principal Investigator:
- Jin-ok Jeong, MD
-
Ilsan, Korea, Republic of
- Recruiting
- Inje University Ilsan Paik Hospital
-
Contact:
- Sung-yun Lee, MD
-
Principal Investigator:
- Sung-yun Lee, MD
-
Incheon, Korea, Republic of
- Terminated
- Gachon University Gil Hospital
-
Jeju, Korea, Republic of
- Recruiting
- Jeju National University Hospital
-
Contact:
- Song-yi Kim, MD
-
Principal Investigator:
- Song-yi Kim, MD
-
Pusan, Korea, Republic of
- Recruiting
- Pusan National University Hospital
-
Contact:
- Jun-hyuck Oh, MD
-
Principal Investigator:
- Jun-hyuck Oh, MD
-
Seoul, Korea, Republic of
- Recruiting
- Korea University Guro Hospital
-
Contact:
- SEUNG-UN NA, MD
-
Principal Investigator:
- SEUNG-UN NA, MD
-
Seoul, Korea, Republic of
- Recruiting
- Chung-Ang University Hospital
-
Contact:
- Sang-wook Kim, MD
-
Principal Investigator:
- Sang-wook Kim, MD
-
Seoul, Korea, Republic of
- Withdrawn
- Kangbuk Samsung Hospital
-
Suwon, Korea, Republic of
- Active, not recruiting
- Ajou University Hospital
-
Ulsan, Korea, Republic of
- Withdrawn
- Ulsan University Hospital
-
Wonju, Korea, Republic of
- Recruiting
- Wonju Severance Christian Hospital
-
Contact:
- Jung-han Yoon, MD
-
Principal Investigator:
- Jung-han Yoon, MD
-
-
Songpa-gu
-
Seoul, Songpa-gu, Korea, Republic of, 138-736
- Recruiting
- Asan Medical Center
-
Contact:
- Seung-jung Park, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with intracoronary imaging
Description
Inclusion Criteria:
- Patients with intracoronary imaging
- Written consent
Exclusion Criteria:
- Severe calcification and/or severe tortuosity
- Lesion with previous bypass graft surgery (CABG)
- Left ventricular ejection fraction less than 30 %
- Coronary spasm
- Life expectancy less than 2 years
- Pregnancy or breast-feeding
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
VH-IVUS
Patients with IVUS-derived virtual histology
|
|
OCT
Patients with Optical coherence tomography
|
|
NIRS
Patients with Near-infrared spectroscopy
|
|
gray scale IVUS
Patients with gray-scale IVUS(Intravascular ultrasound)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Target Vessel Failure
Time Frame: 2 years
|
defined as composite event of cardiac death, non-fatal myocardiac infarction, target vessel revascularization
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cardiac death
Time Frame: 5 years
|
5 years
|
|
All-cause death
Time Frame: 5 years
|
5 years
|
|
Number of myocardial infarction events
Time Frame: 5 years
|
Q wave myocardial infarction or non Q wave myocardial infarction
|
5 years
|
Composite event of death or myocardial infarction
Time Frame: 5 years
|
5 years
|
|
Composite event of cardiac death or myocardial infarction
Time Frame: 5 years
|
5 years
|
|
Target Vessel revascularization
Time Frame: 5 years
|
5 years
|
|
Target Lesion revascularization
Time Frame: 5 years
|
5 years
|
|
Number of stent thrombosis events
Time Frame: 5 years
|
DEFINITE stent thrombosis : acute coronary syndrome and angiographic or pathologic evidence of stent thrombosis; PROBABLE stent thrombosis : unexplained death within 30 days or target-vessel infarction without angiographic information Academic Research Consortium (ARC) stent thrombosis is reported as a cumulative value at different time points and within the different separate time points.
Time 0 is the time point after the guide catheter has been removed.
Acute stent thrombosis: 0-24 hours after stent implantation; Subacute stent thrombosis: >24 hours to 30 days post; late stent thrombosis: >30 days to 1 year post; Very late stent thrombosis: >1 year post;
|
5 years
|
Number of stroke
Time Frame: 5 years
|
5 years
|
|
Procedural success
Time Frame: 7 days
|
Defined as mean lesion diameter stenosis less than 30% and without the occurrence of in-hospital myocardial infarction (MI), target vessel revascularization (TVR), or death
|
7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2016
Primary Completion (Anticipated)
January 1, 2025
Study Completion (Anticipated)
June 1, 2029
Study Registration Dates
First Submitted
June 2, 2016
First Submitted That Met QC Criteria
June 2, 2016
First Posted (Estimate)
June 7, 2016
Study Record Updates
Last Update Posted (Actual)
April 4, 2023
Last Update Submitted That Met QC Criteria
April 3, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AMCCV2016-09
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
This is not a publicly funded trial.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
China National Center for Cardiovascular DiseasesRecruitingLeft Main Coronary Artery DiseaseChina
Clinical Trials on 5-year Follow-up
-
Seung-Jung ParkCardioVascular Research Foundation, KoreaRecruitingPercutaneous Transluminal Coronary AngioplastyKorea, Republic of
-
Ostfold Hospital TrustNot yet recruiting
-
Columbia UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
University of LiegeRecruitingCritical Illness | Bone Loss | Kidney Injury | Muscle LossBelgium
-
University Hospital, Basel, SwitzerlandRecruitingCardiovascular Diseases (CVD)Switzerland
-
Turku University HospitalOulu University Hospital; Kuopio University Hospital; Seinajoki Central Hospital and other collaboratorsNot yet recruitingAppendicitis | Appendix Cancer | Appendix Mass | Appendix Abscess | Appendix Nec | Appendix Tumor | Appendix Diseases
-
University of Alabama at BirminghamRecruiting
-
University College of Northern DenmarkAalborg University; Aalborg Municipality, DenmarkUnknownAccidental FallDenmark
-
Skane University HospitalCompleted
-
Association de Recherche Clinique en RhumatologieRCTsCompletedAxial SpondyloarthritisNetherlands, France, Belgium